Research Corporation Technologies (RCT) announces that Gary M.
Munsinger, Ph.D., resigned from its Board of Directors and all positions
associated with RCT, effective May 15, 2018. Dr. Munsinger was a
founding Director of RCT in 1987 and served as RCT’s CEO from its
founding in 1987 to May 2005. In June 2005, he became Chairman of the
Board, a position he held until his resignation in May. He is succeeded
by John W. McIntyre, who previously served as RCT’s Vice Chairman from
2013 to May 2018. Mr. McIntyre added, “Millions of individuals have
benefited from technologies funded and developed by RCT. Dr. Munsinger
has been the guiding force behind the company’s many successes. RCT is
forever grateful to him for his vision and leadership in developing the
company’s reputation and capabilities over the past 31 years. Through
RCT, Dr. Munsinger has established an enduring legacy in Tucson and the
world. All of us at RCT are proud to be part of this legacy.”
About Research Corporation Technologies
Research Corporation Technologies, Inc. (RCT) is a Tucson, Arizona-based
technology investment and management company that provides early-stage
funding and development for promising biomedical companies and
technologies. RCT has assets of more than $450 million to advance
technology development through flexible, long-term investment options.
RCT focuses on technology investments with origins from universities and
research institutions worldwide. To learn more about RCT, see www.rctech.com.
View source version on businesswire.com: https://www.businesswire.com/news/home/20180618006300/en/